USMLE I

1. The pharmacokinetic properties of a new antihistamine are being studied in normal volunteers during phase I clinical trials. The clearance and half-life of the drug are determined to be 4.0 L/hour and 10 hours, respectively. Which of the following values is the approximate volume of distribution for this drug? 1. The pharmacokinetic properties of a new antihistamine are being studied in normal volunteers during phase I clinical trials. The clearance and half-life of the drug are determined to be 4.0 L/hour and 10 hours, respectively. Which of the following values is the approximate volume of distribution for this drug? A L A L B. 14 L B. 14 L C. 45 L C. 45 L D. 60 L D. 60 L E. 130 L E. 130 L

The correct answer is D. The volume of distribution of a drug can be determined using the following equation: The correct answer is D. The volume of distribution of a drug can be determined using the following equation: t1/2 = (0.693 x Vd)/CL t1/2 = (0.693 x Vd)/CL Therefore, 10 hours = (0.693 x Vd)/(4.0 L/hour), Therefore, 10 hours = (0.693 x Vd)/(4.0 L/hour), 40 hours = x Vd, 40 hours = x Vd, Vd = 58 L which is approximately 60 L Vd = 58 L which is approximately 60 L

2. A cardiovascular pharmacologist is researching the effects of new compounds on arteriolar resistance. Drug X maximally increases vascular resistance by 50% at a dose of 20 mg/mL. Drug Y maximally increases vascular resistance by 75% at a dose of 40 mg/mL. Which of the following conclusions can the researcher draw from this experiment? A. Drug X has a smaller volume of distribution than Drug Y B. Drug X has a shorter half-life than Drug Y C. Drug X is less efficacious than Drug Y D. Drug X is less potent than Drug Y E. Drug X has a lower LD50 than Drug Y

The correct answer is C. The only conclusion that can be drawn from this data is that Drug X is less efficacious than Drug Y. Efficacy is defined as the maximum effect that can be produced by a drug, regardless of dose. Drug X can only produce a 50% change in resistance, whereas Drug Y can produce a 75% change in resistance. Therefore, Drug X is less efficacious than Drug Y. The correct answer is C. The only conclusion that can be drawn from this data is that Drug X is less efficacious than Drug Y. Efficacy is defined as the maximum effect that can be produced by a drug, regardless of dose. Drug X can only produce a 50% change in resistance, whereas Drug Y can produce a 75% change in resistance. Therefore, Drug X is less efficacious than Drug Y.

3.The pharmacokinetic properties of a new drug are being studied under phase 1 clinical trials. The vol of distribution and clearance of the drug is 80 l and 3 l /hr. The half life of the drug is 3.The pharmacokinetic properties of a new drug are being studied under phase 1 clinical trials. The vol of distribution and clearance of the drug is 80 l and 3 l /hr. The half life of the drug is A A B. 14 hrs B. 14 hrs C. 18 hrs C. 18 hrs D. 139 hrs D. 139 hrs

B vd (80) 18 B vd (80) 18 Cl (3) Cl (3)

4. A 32-year-old hollywood star complains of weakness and blurred vision. He notes that these symptoms are typically worsened with effort and improve with rest. Physical examination is remarkable for ptosis and weakness of limb muscles on repetitive testing. 4. A 32-year-old hollywood star complains of weakness and blurred vision. He notes that these symptoms are typically worsened with effort and improve with rest. Physical examination is remarkable for ptosis and weakness of limb muscles on repetitive testing. What is the mechanism of action of the agent that is commonly prescribed for the long-term amelioration of these symptoms? What is the mechanism of action of the agent that is commonly prescribed for the long-term amelioration of these symptoms? A. Carbamylation of acetylcholinesterase A. Carbamylation of acetylcholinesterase B. Competitive inhibition of acetylcholinesterase B. Competitive inhibition of acetylcholinesterase C. Dephosphorylation of acetylcholinesterase C. Dephosphorylation of acetylcholinesterase D. Direct muscarinic receptor agonist D. Direct muscarinic receptor agonist E. Direct muscarinic receptor antagonist E. Direct muscarinic receptor antagonist F. Direct nicotinic receptor agonist F. Direct nicotinic receptor agonist G. Direct nicotinic receptor antagonist G. Direct nicotinic receptor antagonist H. Phosphorylation of acetylcholinesterase H. Phosphorylation of acetylcholinesterase

5. A new antifungal medication is being tested in Phase I clinical trials. Examination of the pharmacokinetic properties of the drug reveals that the half-life of the drug is 3 hours. If a continuous intravenous infusion of this drug were started on a research subject, how long would it take to reach 75% of steady state? 5. A new antifungal medication is being tested in Phase I clinical trials. Examination of the pharmacokinetic properties of the drug reveals that the half-life of the drug is 3 hours. If a continuous intravenous infusion of this drug were started on a research subject, how long would it take to reach 75% of steady state? A. 3 hours A. 3 hours B. 6 hours B. 6 hours C. 9 hours C. 9 hours D. 12 hours D. 12 hours E. 18 hours E. 18 hours

The correct answer is B. The rule of thumb is that the plasma concentration will reach 50% in one half-life, 75% in two half-lives, 87.5% in three half-lives, etc., so that the difference between the current drug level and 100% halves with each half- life. In this instance, it takes two half- lives to reach 75%. The half-live of this drug is 3 hours, so two half-lives is 6 hours. The correct answer is B. The rule of thumb is that the plasma concentration will reach 50% in one half-life, 75% in two half-lives, 87.5% in three half-lives, etc., so that the difference between the current drug level and 100% halves with each half- life. In this instance, it takes two half- lives to reach 75%. The half-live of this drug is 3 hours, so two half-lives is 6 hours.

6. A 15-year-old boy presents to the emergency room with agitation, mydriasis, and hot, dry skin. Physical examination reveals decreased bowel sounds and tachycardia. Assuming that he is suffering from a drug overdose, which class of drugs is most likely responsible for his symptoms? 6. A 15-year-old boy presents to the emergency room with agitation, mydriasis, and hot, dry skin. Physical examination reveals decreased bowel sounds and tachycardia. Assuming that he is suffering from a drug overdose, which class of drugs is most likely responsible for his symptoms? A. Anticholinergic A. Anticholinergic B. Cholinomimetic B. Cholinomimetic C. Opioid C. Opioid D. Salicylate D. Salicylate E. Sedative-hypnotic E. Sedative-hypnotic

7. After a single dose of a drug which has a half-life of 12 hours, what percentage of the dose is still in the body after 1 day? 7. After a single dose of a drug which has a half-life of 12 hours, what percentage of the dose is still in the body after 1 day? A. 87.5% A. 87.5% B. 75% B. 75% C. 50% C. 50% D. 25% D. 25%

9. A 24-year-old farm worker is rushed to a nearby emergency room after an accidental exposure to parathion. He is in respiratory distress and is bradycardic. Which of the following drugs can be given to increase the activity of his acetylcholinesterase? 9. A 24-year-old farm worker is rushed to a nearby emergency room after an accidental exposure to parathion. He is in respiratory distress and is bradycardic. Which of the following drugs can be given to increase the activity of his acetylcholinesterase? A. Atropine B. Deferoxamine C. Dimercaprol D. N-acetylcysteine E. Physostigmine F. Pralidoxime

Pralidoxime (2-PAM) 2-pyridine aldoxime methiodide is an acetylcholinesterase (AChE) reactivating agent. It is only useful for counteracting AChE inhibitors which act by Pralidoxime (2-PAM) 2-pyridine aldoxime methiodide is an acetylcholinesterase (AChE) reactivating agent. It is only useful for counteracting AChE inhibitors which act by phosphorylating the enzyme (organophosphates). Pralidoxime can remove the phosphate group from AChE, thus regenerating the enzyme. phosphorylating the enzyme (organophosphates). Pralidoxime can remove the phosphate group from AChE, thus regenerating the enzyme. This must be done in a timely fashion because normally after the phosphate group is bound to the enzyme, it undergoes a chemical reaction known as "aging." Once this bond ages, pralidoxime will no longer be effective. This must be done in a timely fashion because normally after the phosphate group is bound to the enzyme, it undergoes a chemical reaction known as "aging." Once this bond ages, pralidoxime will no longer be effective.